FIELD: medicine.
SUBSTANCE: invention concerns medical equipment, namely pre-dosed dry powder inhalers. An inhaler contains a dose of dry powdered medicine and a container. The dose of dry powdered medicine is loaded into the container and contains tiotropium particles and particles of at least one dry excipient. The container is provided with dry sealing facilities with high barrier properties, containing aluminium that prevents moisture penetration. The dose of dry powdered medicine in the container is prepared either volumetric, or electric field methods of dose preparation.
EFFECT: application of the invention allows improving stability of powdered tiotropium if used for treating asthma and other respiratory disorders.
18 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICAL DRUG CONTAINING TIOTROPIUM IN MOISTURE-PROOF CONTAINER | 2004 |
|
RU2369385C2 |
| INHALATION COMPOSITIONS CONTAINING MONTELEUKAST ACID AND PDE-4 INHIBITOR OR INHALATION CORTICOSTEROID | 2008 |
|
RU2470639C2 |
| RAPAMYCIN FOR TREATING LYMPHANGIOLEIOMYOMATOSIS | 2014 |
|
RU2707285C2 |
| PHARMACEUTICAL COMPOSITIONS | 2004 |
|
RU2364400C2 |
| INHALED PARTICLES CONTAINING TIOTROPIUM | 2009 |
|
RU2685236C2 |
| AGGREGATED PARTICLES | 2013 |
|
RU2666963C2 |
| DRY POWDER INHALATOR WITH TREATMENT COMPLIANCE/CLAIMS MONITORING DEVICE | 2020 |
|
RU2799355C1 |
| INHALATION DOSAGE FORM OF RAPAMYCIN FOR TREATING PULMONARY HYPERTENSION | 2015 |
|
RU2732908C2 |
| METHODS OF TREATING FUNGAL INFECTIONS | 2019 |
|
RU2820457C2 |
| DRY POWDER COMPOSITIONS REPRESENTED AS PARTICLES WHICH CONTAIN TWO OR MORE ACTIVE INGREDIENTS FOR TREATMENT OF OBSTRUCTIVE OR INFLAMMATORY DISEASES OF RESPIRATORY WAYS | 2012 |
|
RU2629333C2 |
